Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...
In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...
Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein ...
Dr. Ashkan Emadi, principal investigator of a first-in-world phase 2 clinical trial evaluating subcutaneous Blincyto (blinatumomab) for CD19-positive mixed phenotype acute leukemia, sat down for an ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Please provide your email address to receive an email when new articles are posted on . Younger patients deemed MRD negative before transplant who received non-TBI regimens achieved 2-year EFS ...
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...
Outcome analysis of autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Insights from a North African single-institution study. This is an ASCO Meeting Abstract from the ...
WGAL on MSN
Bingo day helps cancer patients learn and cope at Penn State Health Golisano Children’s Hospital
Penn State Health Golisano Children's Hospital uses activities like bingo to support young cancer patients, with significant ...
Leukemic ocular involvement arises from direct infiltration, hematologic derangements (anemia, thrombocytopenia, ...
At a church event, she signed up for the bone marrow donor registry, not knowing if she’d ever be called; only knowing why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results